132
Views
58
CrossRef citations to date
0
Altmetric
Review

Pulmonary Absorption of Peptides and Proteins

Pages 1-20 | Received 19 May 1994, Published online: 27 Sep 2008

References

  • Patton J. S., Platz R. M. Pulmonary delivery of peptides and proteins for systemic action. Adv. Drug Del. Rev. 1992; 8: 179–196
  • Niven R. W. Delivery of biotherapeutics by inhalation aerosols. Pharm. Technol. 1993; 17: 72–82
  • Hollinger M. A. Basic lung structure and function. “Respiratory Pharmacology and Toxicology”. Saunders, Philadelphia 1985; 1–20
  • Braga P. C. Antibiotic penetrability into bronchial mucus: Pharmacokinetics and clinical considerations. Curr. Ther. Res. 1991; 49: 300–327
  • Bolister N., Basker M., Hodges N. A., Marriott C. The diffusion of β-lactam antibiotics through mixed gels of cystic fibrosis-derived mucin and Pseudomonas aeruginosa alginate. J. Antimicrob. Chemother. 1991; 27: 285–293
  • Weibel E. R. “Morphometry of the Human Lung,”. Springer-Verlag, Berlin 1963
  • Gehr P., Bachofen M., Weibel E. R. The normal human lung: Ultrastructure and morphometric estimation of diffusion capacity. Respir. Phys. 1978; 32: 121–140
  • Vaccaro C. A., Brody J. S. Structural features of alveolar wall basement membrane in the adult lung. J. Cell Biol. 1981; 91: 427–437
  • Simionescu D., Simionescu M. Differentiated distribution of the cell surface charge on the alveolar–capillary unit. Microvasc. Res. 1983; 25: 85–100
  • Meyer E. C., Dominguez E. A. M., Bensch K. G. Pulmonary lymphatic and blood absorption of albumin from alveoli. Lab Invest. 1969; 20: 1–8
  • Fox J. F. The permeability of the lungs to antibodies. J Immunol. 1936; 31: 7–23
  • Gaensslen M. Uber Inhalation von Insulin. Klin Wochenschr. 1925; 4: 71–84
  • Drinker C. K., Hardenbergh E. Absorption from the pulmonary alveoli. J. Exp. Med. 1947; 86: 7–18
  • Courtice F. C., Simmonds W. J. Absorption from the lungs. J. Physiol. 1949; 109: 103–116
  • Pircher F. J., Knight C. M., Barry W. F., Temple J. R., Kirsch W. J. Retention, distribution, and absorption of inhaled albumin aerosol and absorbed dose estimates from its 131I and 99mTc labels. Am. J. Roentgenol. 1967; 100: 813–821
  • Sanchis J., Dolovich M., Chalmers R., Newhouse M. Quantitation of regional aerosol clearance in the normal human lung. J. Appl. Physiol. 1972; 33: 757–762
  • Brown R. A., Shanker L. S. Absorption of aerosolized drugs from the rat lung. Drug Metab. Dispos. 1983; 11: 355–360
  • Byron P. R., Philips E. M. Absorption, clearance, and dissolution in the lung. “Respiratory Drug Delivery”, P. R. Byron. CRC Press, Boca Raton 1990; 107–141
  • Niven R. W. Modulated drug therapy with inhalation aerosols. “Drugs and the Pharmaceutical Sciences,”. 1992; vol. 54: 321–359
  • Effros R. M., Mason G. R. Measurements of pulmonary epithelial permeability in vivo. Am. Rev. Respir. Dis. 1983; 127: 559–565
  • Patton J. S., Trinchero P., Platz R. M. Bioavailability of pulmonary delivered peptides and proteins: α-interferon calcitonins, and parathyroid hormones. J. Controlled Rel. 1993; 28: 79–85
  • Richardson J., Bouchard T., Ferguson C. C. Up-take and transport of exogenous proteins by respiratory epithelium. Lab. Invest. 1976; 35: 307–314
  • Adjei A. L., Carrigain P. J. Pulmonary bioavailability of LH-RH analogs: Some biopharmaceutical guidelines. J. Biopharm. Sci. 1992; 3: 247–254
  • Schanker L. S., Mitchell E. W., Brown R. A. Species comparison of drug absorption from the lung after aerosol inhalation or intratracheal injection. Drug Metab. Dispos. 1986; 14: 79–88
  • Smith R. M., Traber L. D., Traber D. L., Spragg R. G. Pulmonary deposition and clearance of aerosolized alproteinase inhibitor administered to dogs and to sheep. J. Clin. Invest. 1989; 84: 1145–1154
  • Patrick G., Stirling C. Measurement of mucociliary clearance from the trachea of conscious and anesthetized rats. J. Appl. Physiol. Respir. Environ. Exercise Physiol. 1977; 42: 451–455
  • Byron P. R. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. J. Pharm. Sci. 1986; 75: 433–438
  • Ilowite J., Smaldone G. C., Perry R. J., Bennett W. D., Foster W. M. Relationship between tracheobronchial particle clearance rates and sites of initial deposition in man. Arch. Environ. Health. 1989; 44: 267–273
  • Oberdorster G. Alveolar clearance of inhaled particles and drugs. Aerosol Age 1991; 34–51
  • Yoshida H., Okumura K., Hori R., Anmo T., Yamaguchi H. Absorption of insulin delivered to rabbit trachea using aerosol dosage form. J. Pharm. Sci. 1979; 68: 670–671
  • Jones A. L., Kellaway I. W., Taylor G. Pulmonary absorption of aerosolized insulin in the rabbit. J. Pharm. Pharmacol. 1988; 40: 92, (Suppl.)
  • Colthorpe P., Farr S. G., Taylor G., Smith I. J., Wyatt D. The pharmacokinetics of pulmonary-delivered insulin: A comparison of intratracheal and aerosol administration to the rabbit. Pharm. Res. 1992; 9: 764–768
  • Sakr F. M. A new approach for insulin delivery via the pulmonary route: Design and pharmacokinetics in non-diabetic rabbits. Int. J. Pharm. 1992; 86: 1–7
  • Okumura K., Iwakawa S., Yoshida T., Seki T., Komada F. Intratracheal delivery of insulin: Absorption from solution and aerosol by rat lung. Int. J. Pharm. 1992; 88: 63–73
  • Glauser F. L., Millen J. E., Falls R. Increased alveolar epithelial permeability with acid aspiration: The effects of high-dose steroids. Am. Rev. Respir. Dis. 1979; 120: 1119–1123
  • Liu F.-Y., Shao Z., Kildsig D. O., Mitra A. K. Pulmonary delivery of free and liposomal insulin. Pharm. Res. 1993; 10: 228–232
  • Weissner J. H., Mar H., Baskin D. G., Hwang K. J. Peptide-carrier interaction: Induction of liposome fusion and aggregation by insulin. J. Pharm. Sci. 1986; 75: 259–263
  • Liu F.-Y., Kildsig D. O., Mitra A. K. Pulmonary biotransformation of insulin in rat and rabbit. Life Sci. 1992; 51: 1683–1689
  • Yamahara H., Kim K.-J., Crandall E. D., Lee V. H. L. Insulin transport by rat alveolar epithelial cell mono-layers. Proc. Int. Symp. Control. Rel. Bioact. Mater. 1993; 20: 276–277
  • Wigley F. M., Londono XJ. H., Wood S. H., Shipp J. C., Waldman R. H. Insulin across respiratory mucosae by aerosol delivery. Diabetes 1971; 20: 552–556
  • Schlüter K. J., Köhler D., Enzmann F., Kerp L. Pulmonary administration of human insulin in volunteers and type I diabetics. Diabetes 1984; 33: 75A, (Suppl. 1)
  • Köhler D., Schlüter K. J., Kerp L., Matthys H. Nicht radioaktives Verhafen zur Messung der Lungenpermeabilität: Inhalation von Insulin. Atemw. Lungenkrkh. 1987; 13: 230–232
  • Elliott R. B., Edgar B. W., Pilcher C. C., Quested C., McMaster J. Parenteral absorption of insulin from the lung in diabetic children. Aust. Paediatr. J. 1987; 23: 293–297
  • Laube B. L., Georgopoulos A., Adams G. K. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. JAMA 1993; 269: 2106–2109
  • Folkesson H. G., Leanderson P., Weström B. R., Tagesson C. Increased lung to blood passage of polyethylene glycols after intratracheal instillation of ferritin and asbestos fibres in the rat. Eur. Respir. J. 1993; 6: 96–101
  • Connelly J. C., Peterson B. T. Clearance of 99mTc-labeled albumin from lungs in anesthetized guinea pigs. Exp. Lung Res. 1993; 19: 237–255
  • Van Scott M. R., Yankaskas J. R., Boucher R. C. Culture of airway epithelial cells: Research techniques. Exp. Lung Res. 1986; 11: 75–93
  • Jorissen M., Van der Scheren B., Van den Berghe H., Cassiman J. J. Contribution of in vitro culture methods for respiratory epithelial cells to the study of the physiology of the respiratory tract. Eur. Respir. J. 1991; 4: 210–217
  • Zeitlin P. L., Loughlin G. M., Guggino W. B. Ion transport in cultured fetal and adult rabbit tracheal epithelia. Am. J. Physiol. 1988; 254: C691–C698
  • Yamaya M., Finkbeiner W. E., Chun S. Y., Widdicombe J. H. Differentiated structure and function of cultures from human tracheal epithelium. Am. J. Physiol. 1992; 262: L713–L724
  • Rannels S. R., Fisher C. S., Hauser L. J., Rannels D. E. Culture of type II pneumocytes on a type II cell-derived fibronectin-rich matrix. Am. J. Physiol. 1987; 253: C759–C765
  • Dobbs L. G., Williams M. C., Gonzalez R. Monoclonal antibodies specific to apical surface of rat alveolar type I cells bind to surfaces of cultured, but not freshly isolated type II cells. Biochim. Biophys. Acta 1988; 970: 146–156
  • Weller N. K., Karnovsky M. J. Identification of a 185 kDa Maclura pomifera agglutinin binding glycoprotein as a candidate for a differentiation marker for alveolar type II cells in adult rat lung. Am. J. Pathol. 1989; 134: 277–285
  • Kawada H., Shannon J. M., Mason R. J. Improved maintenance of adult rat alveolar type II cell differentiation in vitro: Effect of serum-free, hormonally-defined medium and a reconstituted basement membrane. Am. J. Respir. Cell Mol. Biol. 1990; 3: 33–43
  • Danto S. I., Zabski S. M., Crandall E. D. Reactivity of alveolar epithelial cells in primary culture with type I cell monoclonal antibodies. Am. J. Respir. Cell Mol. Biol. 1992; 6: 296–306
  • Lubman R. L., Crandall E. D. Regulation of intracellular pH in alveolar epithelial cells. Am. J. Physiol. 1992; 262: L1–L14
  • Cheek J. M., Evans M. J., Crandall E. D. Type I cell-like morphology in tight alveolar epithelial monolayers. Exp. Cell Res. 1989; 184: 375–387
  • Cheek J. M., Kim K.-J., Crandall E. D. Tight monolayers of rat alveolar epithelial cells: Bioelectric properties and active sodium transport. Am. J. Physiol. 1989; 256: C688–C693
  • Kim K. J., Cheek J. M., Crandall E. D. 14C-Albumin transport across rat alveolar epithelial monolayers. Am. Rev. Respir. Dis. 1989; 139: A477
  • Morimoto K., Yamahara H., Lee V. H. L., Kim K.-J. Dipeptide transport across rat alveolar epithelial cell monolayers. Pharm. Res. 1993; 10: 1668–1674
  • Kim K. J., Crandall E. D. Peptide and protein transport across alveolar epithelium. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 1993; 20: 232–233
  • Smith B. T. Cell line A549: A model system for the study of alveolar type II cell function. Am. Rev. Respir. Dis. 1977; 115: 285–293
  • Widdicombe J. G. Permeability of the airway mucosa in asthma. Eur. Respir. J. 1991; 4: 139s–147s, (Suppl. 13)
  • Gatzy J. T. Ion transport across the excised bullfrog lung. Am. J. Physiol. 1975; 228: 1162–1171
  • Crandall E. D., Kim K. J. Transport of water and solutes across bullfrog alveolar epithelium. J. Appl. Physiol. Respir. Environ. Exercise Physiol. 1981; 50: 1263–1271
  • Dierichs R. Electron microscopic studies of the lung of the frog. Cell Tissue Res. 1975; 160: 399–410
  • Okada Y., Ishiko S., Daido S., Kim J., Ikeda S. Comparative morphology of the lung with special reference to the alveolar epithelial cells. I. Lung of the amphibia. Acta Tuber. Jpn. 1962; 11: 63–72
  • Fischer H., Driessche W. V., Clauss W. Evidence for apical sodium channels in frog lung epithelial cells. Am. J. Physiol. 1989; 256: C764–C771
  • Vergara G. A., Hughes G. M. Phospholipids in washings from the lungs of the frog (Rana pipiens). J. Comp. Physiol. 1980; 139: 117–120
  • Hallman M., Gluck L. Phosphatidylglycerol in lung surfactant. III. Possible modifier of surfactant function. J. Lipid Res. 1976; 17: 257–262
  • Kim K. J., Crandall E. D. Heteropore populations of bullfrog alveolar epithelium. J. Appl. Phsiol. Respir. Environ. Exercise Physiol. 1983; 54: 140–146
  • Kim K. J., Crandall E. D. Sodium-dependent lysine flux across bullfrog alveolar epithelium. J. Appl. Physiol. 1988; 65: 1655–1661
  • Kim K. J. Active Na+ transport across Xenopus lung alveolar epithelium. Respir. Physiol. 1990; 81: 29–40
  • Wall D. A., Pierdomenico D. P., Wilson G. An in vitro pulmonary epithelial system for evaluating peptide transport. J. Control. Rel. 1993; 24: 227–235
  • Wall D. A. Drug transport across alveolar epithelium in vitro. “Pharmaceutical Biotechnology,”. 1994, submitted for publication
  • Wilson G. A., Pierdomenico D., Wall D. A. Biological barriers to the pulmonary absorption of peptides and proteins. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 1992; 19: 214–215
  • Pierdomenico D., Madonna-Langan M., Smith P. L., Wall D. A. An in vitro model for pulmonary epithelial permeability. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 1992; 19: 228–229
  • Mehendale H. M., Angevine L. S., Ohmiya Y. The isolated perfused lung—A critical evaluation. Toxicology 1981; 21: 1–36
  • Byron P. R., Roberts N. S. R., Clark A. R. An isolated perfused rat lung preparation for the study of aerosolized drug deposition and absorption. J. Pharm. Sci. 1986; 75: 168–171
  • Effros R. M., Mason Hukkanen G. R., Silverman P. New evidence for active sodium transport from fluid-filled rat lungs. J. Appl. Physiol. 1989; 66: 906–919
  • Taylor A. E., Gaar K. A. Estimation of equivalent pore radii of pulmonary capillary and alveolar membranes. Am. J. Physiol. 1970; 218: 1133–1140
  • Goodale R. L., Goetzman B., Visscher M. B. Hypoxia and iodoacetic acid and alveolocapillary barrier permeability to albumin. Am. J. Physiol. 1970; 219: 1226–1230
  • Goetzman B. W., Visscher M. B. The effects of alloxan and histamine on the permeability of the pulmonary alveolocapillary barrier to albumin. J. Physiol. 1969; 204: 51–61
  • Wangensteen D., Yankovich R. Alveolar epithelium transport of albumin and sucrose: concentration difference effect. J. Appl. Physiol. 1979; 47: 846–850
  • Johnson L. G., Cheng P. W., Boucher R. C. Albumin absorption by canine bronchial epithelium. J. Appl. Physiol. 1989; 66: 2772–2777
  • Hulbert W. C., Walker D. C., Jackson A., Hogg J. C. Airway permeability to horseradish peroxidase in guinea pigs: The repair phase after injury by cigarette smoke. Am. Rev. Respir. Dis. 1981; 123: 320–326
  • Ranga V., Kleinerman J., Ip M. P. C., Collins A. M. The effect of nitrogen dioxide on tracheal uptake and transport of horseradish peroxidase in the guinea pig. Am. Rev. Respir. Dis. 1980; 122: 483–490
  • Boucher R. C., Ranga V., Pare P. D., Inoue S., Moroz L. A., Hogg J. C. Effect of histamine and methacholine on guinea pig tracheal permeability to HRP. J. Appl. Physiol. Respir. Environ. Exercise Physiol. 1978; 45: 939–948
  • Gatzy J. T. Chemical effects on lung transport. Fed. Proc. 1979; 38: 2234–2239
  • Schneeberger E. E. Structural basis for some permeability properties of the air–blood barrier. Fed. Proc. 1978; 37: 2471–2478
  • Schneeberger-Keeley E. E., Karnovsky M. J. The ultrastructural basis of alveolar-capillary membrane permeability to peroxidase used as a tracer. J. Cell Biol. 1968; 37: 781–793
  • Schneeberger E. E., Karnovsky M. J. The influence of intravascular fluid volume on the permeability of newborn and adult mouse lungs to ultrastructural protein tracers. J. Cell Biol. 1971; 49: 319–334
  • Bensch K. G., Dominguez E. A. M. Studies on the pulmonary air-tissue barrier. IV. Cytochemical tracing of macromolecules during absorption. Yale J. Biol. Med. 1971; 43: 236–241
  • Williams M. C. Endocytosis in alveolar type II cells: Effect of charge and size of tracers. Proc. Natl. Acad. Sci. USA 1984; 81: 6054–6058
  • Williams M. C. Uptake of lectins by pulmonary alveolar type II cells: Subsequent deposition into lamellar bodies. Proc. Natl. Acad. Sci. USA 1984; 81: 6383–6387
  • Williams M. C. Endocytosis and transcytosis by alveolar epithelial cells in the adult rat lung. J. Biopharm. Sci. 1992; 3(1/2)209–214
  • Holtzman E. “Lysosomes,”. Plenum, New York 1989; 39–42
  • Hoover J. L., Rush B. D., Wilkinson K. F., Day J. S., Burton P. S., Vidmar T. J., Ruwart M. J. Peptides are better absorbed from the lung than the gut in the rat. Pharm. Res. 1992; 9: 1103–1106
  • Sheehy A. M., Hoover J. F., Rush B. D., Wilkinson K. F., Vidmar T. J., Ruwart M. J. Intrapulmonary delivery of renin inhibitory peptides results in sustained release due to saturable transport. Pharm. Res. 1993; 10: 1548–1551
  • Niven R. W., Rypacek F., Byron P. R. Solute absorption from the airways of the isolated rat lung. III. Absorption of several peptidase-resistant, synthetic polypeptides: poly-(2-hydroxyethyl)-aspartamides. Pharm. Res. 1990; 7: 990–994
  • Byron P. R., Sun Z., Katayama H., Rypacek F. Solute absorption from the airways of the isolated rat lung. IV. Mechanisms of absorption of fluorophore-labeled poly-α, β-[N(2-hydroxyethyl)-d,l-aspartamide]. Pharm. Res. 1994; 11: 221–225
  • Byron P. R., Rypacek F., Sun Z., Katayama H. Polypeptide absorption in the rat lung: dose and charge dependence. J. Biopharm. Sci. 1992; 3(1/2)227–232
  • Smith P. L., Yeulet S. E., Citerone D. R., Drake F. R., Cook M., Wall D. A., Marcello J. SK&F 110679: Comparison of absorption following oral or respiratory administration. J. Control. Rel. 1994; 28: 67–77
  • Wang L., Toledo-Velasquez D., Schwegler-Berry D., MaRojanasakul J. K. H. Transport and hydrolysis of enkephalins in cultured alveolar epithelial monolayers. Pharm. Res. 1993; 10: 1662–1667
  • Kim K.-J., Le Bon T. R., Shinbane J. S., Crandall E. D. Asymmetric 14C-albumin transport across bullfrog alveolar epithelium. J. Appl. Physiol. 1985; 59: 1290–1297
  • Schnitzer J. E., Oh P. Antibodies to the albumin binding protein, albondin, inhibit transvascular transport of albumin in the rat lung. FASEB J. 1993; 7: A902
  • Ghitescu L., Fixman A., Simionescu M., Simionescu N. Specific binding sites for albumin to plasmalemmal vesicles of continuous capillary endothelium: Receptor-mediated transcytosis. J. Cell Biol. 1986; 102: 1304–1311
  • Crooks P. A., Damani L. A. Drug application to the respiratory tract: Metabolic and pharmacokinetic considerations. “Respiratory Drug Delivery”, P. R. Byron. CRC Press, Boca Raton 1989; 61–90
  • Patterson E. K., Hsiao S.-H., Keppel A. Studies on dipeptidases and aminopeptidases. I. Distinction between aminopeptidase and enzymes that hydrolyze l-leucyl-β-napthylamide. J. Biol. Chem. 1963; 238: 3611–3620
  • Sylvan B., Bois I. Studies on the histochemical “leucine aminopeptidase” reaction. II. Chemical and histochemical comparison of the enzymatic and environmental factors involved. Histochemie 1963; 3: 341–353
  • Gadek J. E., Kalman J. A., Fells G., Weinberger S. E., Horwitz A. L., Reynolds H. Y., Fulmer J. D., Crystal R. G. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 1979; 301: 737–742
  • Hayem A., Scharfman A., Laine A., Lafitte J. J., Sablonniere B. Proteases and antiproteases in bronchoalveolar lavage. Bull Eur. Physiopathol. Respir. 1980; 16: 247–258
  • Janoff A., Raju L., Dearing R. Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers. Am. Rev. Respir. Dis. 1983; 127: 540–544
  • Smith S. F., Guz A., Cooke N. T., Burton G. H., Tetley T. D. Extracellular elastolytic activity in human lung lavage: A comparative study between smokers and non-smokers. Clin. Sci. 1985; 69: 17–27
  • Lee C. T., Fein A. M., Lippman M., Holtzman H., Kimbel P., Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N. Engl. J. Med. 1981; 304: 192–196
  • Fujita J., Nelson N. L., Daughton D. M., Dobry C. A., Spurzem J. R., Irino S., Rennard S. I. Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema. Am. Rev. Respir. Dis. 1990; 142: 57–62
  • Wall D. A., Lanutti A. High levels of exopeptidase activity are present in rat and canine bronchoalveolar lavage fluid. Int. J. Pharm. 1993; 97: 171–181
  • Orlowski M., Orlowski J., Lesser M., Kilburn K. H. Proteolytic enzymes in bronchopulmonary lavage fluids: Cathepsin B-like activity and prolyl endopeptidase. J. Lab. Clin. Med. 1981; 97: 467–476
  • Janoff A. Elastases and emphysema. Am. Rev. Respir. Dis. 1985; 132: 417–433
  • Adibi S. A., Morse E. L. Intestinal transport of dipeptides in man: Relative importance of hydrolysis and intact absorption. J. Clin. Invest. 1971; 50: 2266–2275
  • Stratford R. E., Lee V. H. L. Aminopeptidase activity in homogenates of various absorptive mucosae in the albino rabbit: Implications in peptide delivery. Int. J. Pharm. 1986; 30: 73–82
  • Borson D. B. Roles of neutral endopeptidase in airways. Am. J. Physiol. 1991; 260: L212–L225
  • Johnson A. R., Ashton J., Schulz W., Erdös E. G. Neutral metalloendo-peptidase in human lung tissue and cultured cells. Am. Rev. Respir. Dis. 1985; 132: 564–568
  • Patton J. S., McCabe J. G., Hansen S. E., Daugherty A. L. Absorption of human growth hormone from the rat lung. Biotechnol. Ther. 1990; 1: 213–228
  • Bocci V., Pessina G. P., Pacini A., Paulesu L., Muscettola M., Mogesen K. E. Pulmonary catabolism of interferons: Alveolar absorption of 125I-labelled human interferon alpha is accompanied by partial loss of biological activity. Anti-viral Res. 1984; 4: 211–220
  • Caughey G. H. Peptide metabolism by lung and airway peptidases. J. Biopharm. Sci. 1992; 3: 233–240
  • Ryan J. W. Peptidase enzymes of the pulmonary vascular surface. Am. J. Physiol. 1989; 257: L53–L60
  • Sharf H., Said S. I. Tracheal relaxant response to vasoactive intestinal peptide (VIP): Influence of airway epithelium and peptidases. FASEB J. 1993; 7: A686
  • Lilly C. M., Martins M. A., Drazen J. M. Peptidase modulation of vasoactive intestinal peptide pulmonary relaxation in tracheal superperfused guinea pig lungs. J. Clin. Invest. 1993; 91: 235–243
  • Huland E., Huland H., Heinzer H. Interleukin-2 by inhalation: Local therapy for metastatic renal cell carcinoma. J. Urol. 1992; 147: 344–348
  • Counts D. F., Knighten P. Collagen and non-collagen protein synthesis in the lungs of rats exposed to a trypsin aerosol. Connect. Tissue Res. 1977; 5: 165–170
  • Colombo C., Steinetz B. G. Lung enzymes in emphysematous rats: Effects of progestogens, antiphlogistics, and metabolic inhibitors. Arch. Intern. Pharmacodyn. Ther. 1975; 216: 86–96
  • Jay S. J. Pulmonary alveolar proteinosis: Successful treatment with aerosolized trypsin. Am. J. Med. 1979; 66: 348–354
  • Bennett D. B., Tyson E., Nerenberg C. A., Mah S., de Groot J. S., Teitelbaum Z. Pulmonary delivery of detirelix by intratracheal instillation and aerosol inhalation in the briefly anesthetized dog. Pharm. Res. 1994; 11: 1048–1055
  • Adjei A., Doyle R., Pratt M., Finley R., Johnson E. Bioavailability of leuprolide following intratracheal administration to beagle dogs. Int. J. Pharm. 1990; 61: 135–144
  • Hubbard R. C., Crystal R. G. Strategies for aerosol therapy of al-antitrypsin deficiency by the aerosol route. Lung (Suppl.) 1990; 565–578
  • Hubbard R. C., McElvaney N. G., Birrer P., Shak S., Robinson W. W., Jolley C., Wu M., Chernick M. S., Crystal R. G. A preliminary study of aerosolized recombinant human DNase I in the treatment of cystic fibrosis. N. Engl. J. Med. 1992; 326: 812–815
  • Ranasinha C., Assoufi B., Shak S., Christiansen C., Fuchs H., Empey D., Geddes D., Hodson M. Efficacy and safety of short-term administration of aerosolized recombinant human DNase I in adults with stable stage cystic fibrosis. Lancet 1993; 342: 199–202
  • Willoughby J. B., Willoughby W. F. In vivo responses to inhaled proteins. J. Immunol. 1977; 119: 2137–2146
  • Clancy R. L., Cripps A. W. The handling of inhaled antigen within the respiratory tract. Adv. Drug Del. Rev. 1990; 5: 63–72
  • Blanchard G. C., Pathak S. K., Taylor C. G., Berman L. D. Lung nonresponsiveness produced in guinea pigs by aerosolized antigen. I. Nonresponsiveness is not antigen specific. Int. Archs. Allergy Appl. Immunol. 1987; 84: 373–379
  • Wilson B. D., Huang C. J., Moore V. L., Calvanico N. J. The development of granulomatous pulmonary inflammation in rabbits by aerosol challenge. Cell Immunol. 1982; 67: 90–100
  • Calvanico N. J., Garancis J. C. Specificity and duration of post-inflammatory suppression in rabbit lungs challenged with aerosolized antigen. Clin. Exp. Immunol. 1985; 59: 336–342
  • Braley J. F., Dawson C. A., Moore V. L., Cozzini B. O. Absorption of inhaled antigen into the circulation of isolated lungs from normal and immunized rabbits. J. Clin. Invest. 1978; 61: 1240–1246
  • Geoghegan W. D., Dawson C. A., Calvanico N. J. The effect of IgG and IgG fragments on the absorption of in-haled antigens across the air-blood barrier of isolated perfused rabbit lungs. Immunology 1981; 44: 331–337
  • Holt P. G., Oliver J., Bilyk N., McMenamin C., McMenamin P. G., Krall G., Thepen T. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 1993; 177: 397–407
  • Anonymous. Genetech's Pulmozyme for cystic fibrosis. SCRIP 1994, 1886/87, 28
  • Aitken M. L., Burke W., McDonald G., Shak S., Montgomery A. B., Smith A. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. JAMA 1992; 267: 1947–1951
  • Cipolla D. C., Clark A. R., Chan H.-K., Gonda I., Shire S. J. Assessment of aerosol delivery systems for recombinant human deoxyribonuclease s.t.p. Pharm. Sci. 1994; 4: 50–62
  • Cipolla D., Gonda I., Shire S. J. Characterization of aerosols of human recombinant deoxyribonuclease I (rhDNase) generated by jet nebulizers. Pharm. Res. 1994; 11: 491–498
  • Creasia D. A., Saviolakis G. A., Bostian K. A. Efficacy of inhaled insulin: Effect of adjuvant. FASEB J. 1988; 2: A537
  • Ohtani T., Murakami M., Yamamoto A., Takada K., Muranishi S. Effect of absorption enhancers on pulmonary absorption of fluorescien isothiocyanate dextrans with various molecular weights. Int. J. Pharm. 1991; 77: 141–150
  • Morita T., Yamamoto A., Hashida M., Sezaki H. Effects of various absorption promoters on pulmonary absorption of drugs with different molecular weights. Biol. Pharm. Bull. 1993; 16: 259–262
  • Padmanabhan R. V., Gudapaty R., Liener I. E., Schwartz B. A., Hoidal J. R. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. Am. Rev. Respir. Dis. 1985; 132: 164–167
  • Thibeault D. W., Rezaiekhaligh M., Mabry S., Beringer T. Prevention of chronic pulmonary oxygen toxicity in young rats with liposome-encapsulated catalase administered intratracheally. Pediatr. Pulmonol. 1991; 11: 318–327
  • Meisner D. Liposomes as a pulmonary drug delivery system. “Pharmaceutical Particulate Carriers: Therapeutic Applications”, A. Rolland. Dekker, New York 1993; 31–63
  • Montgomery A. B., Dabs R. J., Luce J. M., Corkery K. J., Turner J., Brunette E. N., Lin E. T., Hopewell P. C. Selective delivery of pentamidine to the lung by aerosol. Am. Rev. Respir. Dis. 1988; 137: 477–478
  • Smith L. J., Anderson J., Shamsuddin M. Glutathione localization and distribution after intratracheal instillation. Am. Rev. Respir. Dis. 1992; 145: 153–159
  • Smith P. L., Marcello J., Chiossone D. C., Orner D., Hidalgo I. J. Absorption of an RGD peptide (SK&F 106760) following intratracheal administration in the rat. Int. J. Pharm. 1994; 106: 95–101
  • Yasuda T., Gold H. K., Kohmura Guerrero C., Yaoita H., Fallon J. T., Bunting S., Collen D. Intravenous and endobronchial administration of G4120, a cyclic Arg–Gly–Asp–containing platelet GPIIb/IIIa receptor-blocking pentapeptide, enhances and sustains coronary arterial thrombosis with rt-PA in a canine preparation. Arteriosclerosis Thrombosis 1993; 13: 738–747
  • Folkesson H. G., Weström B. R., Karlsson B. W. Permeability of the respiratory tract to different-sized macro-molecules after intratracheal instillation in young and adult rats. Acta Physiol. Scand. 1990; 139: 347–354
  • Folkesson H. G., Westrom B. R., Pierzynowski S. G., Karlsson B. W. Lung to blood passage of different-sized molecules during lung inflammation in the rat. J. Appl. Physiol. 1991; 71: 1106–1111
  • Folkesson H. G., Weström B. R., Dahlback M., Lundin S., Karlsson B. W. Passage of aerosolized BSA and the nona-peptide dDAVP via the respiratory tract in young and adult rats. Exp. Lung Res. 1992; 18: 595–614
  • Burckart G. J., Dowling R., Zenati M., Yousem S. A., Venkataramanan R., Griffith B. P. Cyclosporine administration by aerosol. J. Clin. Pharm. 1989; 29: 832
  • Adjei A., Garren J. Pulmonary delivery of peptide drugs: Effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers. Pharm. Res. 1990; 7: 565–569
  • Niven R. W., Lott F. D., Cribbs J. M. Pulmonary absorption of recombinant methionyl human granulocyte colony stimulating factor (rhuG-CSF) after intratracheal instillation to the hamster. Pharm. Res. 1993; 10: 1604–1610
  • Kinnula V., Mattson K., Cantell K. Pharmacokinetics and toxicity of inhaled human interferon-α in patients with lung cancer. J. Interferon Res. 1989; 9: 419–423
  • Maasilta P., Halme M., Mattson K., Cantell K. Pharmacokinetics of inhaled recombinant and natural alpha interferon. Lancet 1991; 337: 371
  • Takada K., Yamamoto M., Asada S. Evidence for the pulmonary absorption of fluorescent labeled macromolecular compounds. J. Pharm. Dyn. 1978; 1: 281–287
  • Patton J. S., Fuchs H. J., Moore J. A., Gustafson H., Keller G. A., Daugherty A. L. Pulmonary delivery of peptide and protein drugs. Proc. Int. Symp. Control. Rel. Bioact. Mater. 1990; 17: 214–215
  • Folkesson H. G., Hedin L., Weström B. R. Lung to blood passage of human growth hormone after intratracheal instillation: Stimulation of growth in hypophysectomized rats. J. Endocrinol. 1992; 134: 197–203
  • Moore J. A., Chow P. C., Sinieropi D., Dere R., Green J. D., Mordenti J. Aerosol exposure of rats and monkeys to recombinant human deoxyribonuclease I (rhDNase). Pharm. Res. 1991; 8: S55
  • Conner M. W., Chaudhuri I., Rogers A. E., Amdur M. O. Kinetics of respiratory tract absorption and plasma clearance of horseradish peroxidase in guinea pigs. Fundam. Appl. Toxicol. 1985; 5: 99–104
  • Hubbard R. C., Casolaro M. A., Mitchell M., Sellers S. E., Arabia F., Matthay M. A., Crystal R. G. Fate of aerosolized recombinant DNA-produced αl-antitrypsin: Use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance. Proc. Natl. Acad. Sci. USA 1984; 86: 680–684
  • Schultz A. L., Grismer J. T., Grande F. Absorption of radioactive albumin from the lungs of normal dogs. J. Lab. Clin. Med. 1963; 61: 494–500
  • Bensch K. G., Dominguez E., Liebow A. A. Absorption of intact protein molecules across the pulmonary air–tissue barrier. Science 1967; 157: 1204–1206
  • Dominguez E. A. M., Liebow A. A., Bensch K. G. Studies on the pulmonary air–tissue barrier. I. Absorption of albumin by the alveolar wall. Lab. Invest. 1967; 16: 905–911
  • Matthay M. A., Landolt C. C., Staub N. C. Differential liquid and protein clearance from the alveoli of anesthetized sheep. J. Appl. Physiol. Respir. Environ. Exercise Physiol. 1982; 53: 96–104
  • Matthay M. A., Berthiaume Y., Staub N. C. Longterm clearance of liquid and protein from the lungs of unanesthetized sheep. J. Appl. Physiol. 1985; 59: 928–934
  • Azghani A. O., Connelly J. C., Peterson B. T., Gray L. D., Collins M. L., Johnson A. R. Effects of Pseudomonas aeruginosa elastase on alveolar epithelial permeability in guinea pigs. Infect. Immun. 1990; 58: 433–438
  • Choi H.-S. H., Lesser M., Cardozo C., Orlowski M. Immunohistological localization of endopeptidase 24.15 in rat trachea, lung tissue, and alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1990; 3: 619–624
  • Gossrau R. Cytochemistry of membrane proteases. Histochem. J. 1985; 17: 737–771
  • Sannes P. L. Subcellular localization of dipeptidyl peptidase II and IV in rat and rabbit alveolar macrophages. J. Histochem. Cytochem. 1983; 31: 684–690
  • Krepela E., Viccar J., Zizková L., Kasafirek E., Kolár Z., Lichnovsky V. Dipeptidyl peptidase IV in mammalian lungs. Lung 1985; 163: 33–54
  • Ryan U. S., Ryan J. W., Whitaker C., Chiu A. Localization of angiotensin converting enzyme (kininase II): Immunocytochemistry and immunofluorescence. Tissue Cell 1976; 8: 125–145
  • Ryan U. S., Ryan J. W. Endothelial cells and inflammation. Clin. Lab. Med. 1983; 3: 577–599
  • Nagae A., Abe M., Becker R. P., Deddish P. A., Skidgel R. A., Erdös E. G. High concentration of carboxypeptidase M in lungs: Presence of the enzyme in alveolar type I cells. Am. J. Respir. Cell Mol. Biol. 1993; 9: 221–229

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.